Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03518775 · ClinicalTrials.gov registry record
Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam
A clinical trial of Cornea, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 98
- Enrollment target
- 1
- Study location
NCT03518775: Completed study of Cornea, sponsored by Carl Zeiss Meditec.
NCT03518775 is a study of Cornea that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 98 participants, above the 60-participant average among 3 other Cornea trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03518775, a study of Cornea, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are to determine the agreement of measurements between the IOLMaster 700 SW Vers. 1.70 and IOLMaster 700 SW Vers. 1.50 and Pentacam, as well as to evaluate the repeatability and reproducibility of the IOLMaster 700 SW Vers 1.70. The following parameters will be evaluated for Total Keratometry, (TK) and Posterior Corneal Surface (PCS): * cylinder (CYL), Axis (A) * spherical equivalent (SE) Specific Objectives: 1. To compare the agreement of SE between IOLMaster 700 SW Vers. 1.70 and IOLMaster 700 SW Vers. 1.50 (Carl Zeiss Meditec AG, Jena, Germany) 2. To compare the agreement of Cylinder magnitude and axis between IOLMaster 700 SW Version 1.70 and Pentacam 3. To evaluate the repeatability and reproducibility of the IOLMaster 700 SW Vers. 1.70 for all measurement parameters listed above
Primary Outcome
IOLMaster 700 Vers. 1.70 SE\_TK (Spherical Equivalent\_Total Keratometry) Measurements will be compared to IOLMaster 700 SW Vers. 1.50 SE\_K (Spherical Equivalent\_Keratometry) Measurements for Agreement.
Conditions Studied
Interventions
- DEVICE Biometry
Study Locations (1)
Texas
- Slade & Baker Vision - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2018-04-20 |
What the finished NCT03518775 record still lists
NCT03518775 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target, above the 60-participant average among 3 other Cornea trials with a reported enrollment target (63% higher).
The record links to 1 condition, with Cornea appearing as the primary indexed condition, and to 1 intervention - of which Biometry is the first listed.
NCT03518775 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03518775 about?
NCT03518775 is a clinical study titled "Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam". The objectives of this study are to determine the agreement of measurements between the IOLMaster 700 SW Vers. 1.70 and IOLMaster 700 SW Vers. 1.50 and Pentacam, as well as to evaluate the repeatability and reproducibility of the IOLMaster 700 SW Vers 1.70. The following parameters will be evaluate...
What is the current status of trial NCT03518775?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2018-03-16. Estimated completion is 2018-04-20.
What conditions does trial NCT03518775 study?
This clinical trial studies the following conditions: Cornea.
What interventions are being tested in trial NCT03518775?
The interventions under investigation include: Biometry (DEVICE).
Who is sponsoring clinical trial NCT03518775?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03518775 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cornea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI